Earnings season will likely keep the tape jumpy this week, and the options market is already sketching out where the biggest post-print air pockets — and upside gaps — could show up, according to Benzinga Pro.
This is a Benzinga-selected watchlist that runs from large-cap healthcare to high-beta software and storage names. The marquee name on the list is Eli Lilly, but the largest implied move is saved for the final section as the countdown runs from the least volatile setup to the most.
9. Gilead Sciences | Mkt Cap: $161B | Implied Move: 6.72%
Gilead Sciences Inc. (NASDAQ:GILD) reports second quarter of 2026 results on Tuesday, after the closing bell.
Wall Street is looking for a $7.14 per share loss on revenue of $7.40 billion, versus $2.01 in earnings per share on $7.08 billion a year ago — a setup that puts extra weight on the company’s commentary around what’s driving the swing.
